Correlation of 6-min walk test with left ventricular function and quality of life in heart failure due to Chagas disease
Related Experiment Video
Updated: Feb 24, 2026

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Mayara C Chambela1, Mauro F F Mediano1, Roberto R Ferreira2
1Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Insights
The six-minute walk test (6MWT) distance correlates with heart function and quality of life in Chagas Disease (ChD) patients with heart failure. This test can help identify patients needing specialized care in resource-limited areas.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Chagas Disease (ChD) is a parasitic infection that can lead to heart failure.
- Left ventricular dysfunction and reduced quality of life are common in advanced ChD.
- The six-minute walk test (6MWT) is a common functional assessment tool.
Purpose of the Study:
- To assess the correlation between the 6MWT distance and left ventricular function.
- To evaluate the relationship between 6MWT distance and quality of life in ChD patients with heart failure.
Main Methods:
- A cross-sectional study included adult patients with ChD and heart failure.
- Standardized 6MWT was performed.
- Echocardiography, brain natriuretic peptide (BNP) levels, and quality of life questionnaires (SF-36, MLHFQ) were used.
Main Results:
- The average 6MWT distance was 337 ± 105 meters.
- Distance correlated negatively with BNP, quality of life scores (MLHFQ), pulmonary artery systolic pressure, and diastolic dysfunction.
- Distance correlated positively with several SF-36 quality of life domains.
Conclusions:
- The 6MWT distance is a useful indicator of cardiac function and quality of life in ChD patients with heart failure.
- The 6MWT can be a valuable tool for patient stratification and management in resource-limited settings.
Objectives:
To evaluate the correlation of the total distance walked during the six-minute walk test (6MWT) with left ventricular function and quality of life in patients with Chagas Disease (ChD) complicated by heart failure.
Methods:
This is a cross-sectional study of adult patients with ChD and heart failure diagnosed based on Framingham criteria. 6MWT was performed following international guidelines. New York Heart Association functional class, brain natriuretic peptide (BNP) serum levels, echocardiographic parameters and quality of life (SF-36 and MLHFQ questionnaires) were determined and their correlation with the distance covered at the 6MWT was tested.
Results:
Forty adult patients (19 male; 60 ± 12 years old) with ChD and heart failure were included in this study. The mean left ventricular ejection fraction was 35 ± 12%. Only two patients (5%) ceased walking before 6 min had elapsed. There were no cardiac events during the test. The average distance covered was 337 ± 105 metres. The distance covered presented a negative correlation with BNP (r = -0.37; P = 0.02), MLHFQ quality-of-life score (r = -0.54; P = 0.002), pulmonary artery systolic pressure (r = -0.42; P = 0.02) and the degree of diastolic dysfunction (r = -0.36; P = 0.03) and mitral regurgitation (r = -0.53; P = 0.0006) and positive correlation with several domains of the SF-36 questionnaire.
Conclusions:
The distance walked during the 6MWT correlates with BNP, quality of life and parameters of left ventricular diastolic function in ChD patients with heart failure. We propose this test to be adopted in endemic areas with limited resources to aid in the identification of patients who need referral for tertiary centres for further evaluation and treatment.
More Related Videos
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Cardiomyopathy VI: Nursing Management
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VI: Adjunct Therapies